Schlesinger: For advanced cSCC, immunotherapy has been a game-changer. The first immunotherapy drugs approved in the space were PD-1 inhibitors such as cemiplimab (Libtayo; Regeneron) and ...
Todd Schlesinger, MD, is the founder and director of the Dermatology & Laser Center of Charleston and the Clinical Research Center of the Carolinas. Immunotherapies are transforming treatment and ...
A medically trained LLM screened 1476 EMR records in one week, synthesizing structured variables and free-text notes to ...
Medicaid managed care organizations should prioritize children in low-opportunity neighborhoods to optimize health care utilization, improve minority health, and address health-related social needs.
In 524,817 adults with T2D, GLP-1 RA use was associated with lower incident alcohol, cocaine, cannabis, opioid, and nicotine ...
The rise in CRC in adults younger than 65 underscores the need for early screening and prevention efforts. The report’s ...
The Inflation Reduction Act (IRA) represents a transformative shift in US health care policy by enabling Medicare to negotiate drug prices for high-expenditure medicatio ...
In this episode titled, ‘Economic Impact and Unmet Needs in ATTR-CM,’ Dr. Alexander outlines the key cost drivers of ATTR-CM from a clinical perspective, noting that patients typically see 4 to 5 ...
In this opening episode titled, ‘Transthyretin Amyloid Cardiomyopathy (ATTR-CM): Clinical Burden and Diagnostic Challenges,’ moderator, Dr. Ryan Haumschild, and panelist, Dr. Kevin Alexander, ...
Health inequities add $360 billion yearly; see how employers uncover disparities in claims, rethink deductibles, and invest in prevention to curb costs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results